Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults

References

• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Brown TE. Executive functions and attention deficit hyperactivity disorder: Implications of two conflicting views. Int J Disability Develop Educ. 2006;53(1):35–46
   Google Scholar
• . Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci. 2006;10(3):117–123
   PubMed Web of Science ®Google Scholar
• . Barkley RA. Deficient emotional self-regulation is a core component of attention-deficit/hyperactivity disorder. In press. J ADHD Relate Disord.
   Google Scholar
• . Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65–94
   PubMed Web of Science ®Google Scholar
• . Brown TE. DSM-IV: ADHD and executive function impairments. Adv Stud Med. 2002;2(25):910–914
   Google Scholar
• . Brown TE. Brown Attention-Deficit Hyperactivity Disorder Scales for Adolescents and Adults. San Antonio, TX: The Psychological Corporation, Harcourt Assessment; 1996:1–102
   Google Scholar
• . Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry. 2005;57(11):1336–1346
   PubMed Web of Science ®Google Scholar
• . Biederman J, Petty C, Fried R, . Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(10):1730–1738
   PubMed Web of Science ®Google Scholar
• . Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18(3):485–503
   PubMed Web of Science ®Google Scholar
• . Doyle AE. Executive functions in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006;67( suppl 8):21–26
   PubMed Web of Science ®Google Scholar
• . Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJ. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224–1230
   PubMed Web of Science ®Google Scholar
• . Brown TE, Reichel PC, Quinlan DM. Executive function impairments in high IQ adults with ADHD. J Atten Disord. 2009;13(2):161–167
   PubMed Web of Science ®Google Scholar
• . Brown T. Attention Deficit Disorder: The Unfocused Mind in Children and Adults. New Haven, CT: Yale University Press; 2005
   Google Scholar
• . Shallice T, Burgess PW. Deficits in strategy application following frontal lobe damage in man. Brain. 1991;114(pt 2):727–741
   PubMed Web of Science ®Google Scholar
• . Lawrence V, Houghton S, Tannock R, Douglas G, Durkin K, Whiting K. ADHD outside the laboratory: Boys' executive function performance on tasks in videogame play and on a visit to the zoo. J Abnorm Child Psychol. 2002;30(5):447–462
   PubMed Web of Science ®Google Scholar
• . Kooij JJS, Marije Boonstra A, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord. 2008;11(4):445–458
   PubMed Web of Science ®Google Scholar
• . Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines. CADDRA 2008. http://www.caddra.ca/cms4/index.php?option=com_content&view=article&id=26&Itemid=353&lang=en. Accessed December 14, 2009
   Google Scholar
• . Atkinson M, Hollis C. NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed. 2010;95(1):24–27
   PubMed Web of Science ®Google Scholar
• . Vyvanse [package insert]. Wayne, PA: Shire US Inc; 2010
   Google Scholar
• . Adler LA, Goodman DW, Kollins SH, ; 303 Study Group. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008; 69(9):1364–1373
   PubMed Web of Science ®Google Scholar
• . Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J; 316 Study Group. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using the adult workplace environment design. Behav Brain Funct. 2010; 6(1):34
   PubMedGoogle Scholar
• . Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450–463
   PubMed Web of Science ®Google Scholar
• . Wigal SB, Kollins SH, Childress AC, Squires L; 311 Study Group. A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health. 2009; 3(1):17
   PubMedGoogle Scholar
• . American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000:85–93
   Google Scholar
• . DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998
   Google Scholar
• . Faries DE, Yalcin I, Harder D, Heiligenstein JH. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Attent Disord. 2001;5(2):107–115
   Google Scholar
• . Steele M, Jensen PS, Quinn DMP. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther. 2006;28(11):1892–1908
   PubMed Web of Science ®Google Scholar
• . Swanson JM, Kraemer HC, Hinshaw SP, . Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40(2):168–179
   PubMed Web of Science ®Google Scholar
• . Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L; 304 Study Group. Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. CNS Spectr. 2009; 14(10):573–585
   PubMed Web of Science ®Google Scholar
• . Biederman J, Mick E, Surman C, . A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829–835
   PubMed Web of Science ®Google Scholar
• . Medori R, Ramos-Quiroga JA, Casas M, . A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008;63(10):981–989
   PubMed Web of Science ®Google Scholar
• . Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93–101
   PubMed Web of Science ®Google Scholar
• . Weisler RH, Biederman J, Spencer TJ, . Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11(8):625–639
   PubMed Web of Science ®Google Scholar
• . Biederman J, Spencer TJ, Wilens TE, Weisler RH, Read SC, Tulloch SJ; SLI381.304 Study Group. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005; 10(12 suppl 20):16–25
   PubMedGoogle Scholar
• . Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L; Adult ADHD Research Group. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007; 61(12):1380–1387
   PubMed Web of Science ®Google Scholar
• . Brown TE, Spencer TJ, Silverberg A, Youcha SH. Improved executive functions with triple-bead mixed amphetamine salts (spd465), a novel, enhanced extended-release amphetamine formulation, in adults with ADHD. Poster presented at: New Clinical Drug Evaluation Unit (NCDEU) 47th Annual Meeting; June 11–14, 2007; Boca Raton, FL
   Google Scholar
• . Fallu A, Richard C, Prinzo R, Binder C. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Curr Med Res Opin. 2006;22(12):2557–2566
   PubMed Web of Science ®Google Scholar
• . Hazel-Fernandez LA, Klorman R, Wallace JM, Cook S. Methylphenidate improves aspects of executive function in African American children with ADHD. J Atten Disord. 2006;9(4):582–589
   Google Scholar
• . Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med. 1999;29(3):527–538
   PubMed Web of Science ®Google Scholar
• . Qian Y, Cao QJ, Wang YF. Effect of extended-release methylphenidate on the ecological executive function for attention deficit hyperactivity disorder [in Chinese]. Beijing Da Xue Xue Bao. 2007;39(3):299–303
   Google Scholar
• . Spencer TJ, Adler LA, Weisler RH, Youcha SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69(9):1437–1448
   PubMed Web of Science ®Google Scholar
• . Brown TE, Holdnack J, Saylor K, . Effect of Atomoxetine on Executive Function Impairments in Adults with ADHD [published online ahead of print December 21, 2009]. J Atten Disord.
   Google Scholar
• . Gioia GA, Isquith PK, Guy SC, Kenworthy L. BRIEF: Behavior Rating Inventory of Executive Function: Professional Manual. Lutz, FL: Psychological Assessment Resources, Inc; 2000
   Google Scholar
• . Findling RL, Ginsberg LD, Jain R, Gao J. Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization study. J Child Adolesc Psychopharmacol. 2009;19(6):649–662
   PubMed Web of Science ®Google Scholar
• . Stavro GM, Ettenhofer ML, Nigg JT. Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc. 2007;13(2):324–334
   PubMed Web of Science ®Google Scholar
• . Rabbit P. Introduction: Methodologies and models in the study of executive function. In: Rabbit P, ed. Methodology of Frontal and Executive Function. Psychology Press Ltd; 1997
   Google Scholar
• . Alderman N, Burgess PW, Knight C, Henman C. Ecological validity of a simplified version of the multiple errands shopping test. J Int Neuropsychol Soc. 2003;9(1):31–44
   PubMed Web of Science ®Google Scholar